Reaction: Quizartinib to 1 product

Reaction
Quizartinib
DB12874
AC886
DBMET03691
Reaction type
oxidation
Direction
Major circulating metabolite?
Yes
Spontaneous?
No
Activity
active
References
  1. FDA Approved Drug Products: VANFLYTA® (quizartinib) tablets, for oral use [Link]
  2. EMA Assessment Report: quizartinib [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Cytochrome P450 3A4Not AvailableNot Availableconfirmed
Cytochrome P450 3A7Not AvailableNot Availableconfirmed